Peptides, short chains of amino acids, have become a significant focus in scientific research due to their potential in understanding biological processes, exploring potential drug targets, and advancing our knowledge of diseases. However, the use of peptides is not without regulatory oversight. The U.S. Food and Drug Administration (FDA) has implemented restrictions on certain peptides, impacting both the medical and research communities.
FDA Restrictions on Peptides
The FDA has not declared it illegal for pharmacies to obtain peptide substances. However, it has made it more challenging for doctors to prescribe peptides from compounding pharmacies. The FDA updated its list of bulk drug substances under Section 503A, placing several peptides in Category 2 due to identified significant safety risks. This categorization doesn’t make these peptides illegal but indicates that pharmacies may be hesitant to stock them due to potential FDA regulatory action.
Write a comment ...